Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
Status:
Unknown status
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The efficacy measure of hUC-MSC in the treatment of proliferative lupus nephritis on
remission of lupus nephritis (combined partial and complete remission) in terms of
stabilization and improvement in renal function.